Wednesday, 25 March 2020 12:53

HealthMatch releases COVID-19 clinical trials tracker Featured

HealthMatch CEO Manuri Gunawardena HealthMatch CEO Manuri Gunawardena

Australian clinical trials startup HealthMatch has released a global COVID-19 clinical trials tracker to map developments on research breakthroughs around the world.

HealthMatch, which helps researchers run clinical trials for oncology and chronic conditions, is also opening its platform to help recruit coronavirus trial patients for free to expedite COVID-19 research in Australia.

Writing on the HealthMatch website, company Founder and CEO Manuri Gunawardena said that with the coronavirus pandemic gripping the nation- and with global trials now well underway - the importance of clinical testing is urgent, and for many countries, critical.

“In response to the COVID-19 Pandemic, HealthMatch will provide patient recruitment services free to all organisations (public and private) for COVID-19 research. This includes pharmaceutical, biotechnology, NFP, Universities, Government and other organisations unified in the fight against COVID-19,” Gunawardena said.

“HealthMatch has developed a free, public global clinical trial tracker available here.

“We know that this is a difficult time for many researchers and patients who have also had their clinical trials on other conditions disrupted, delayed or abandoned. When hospitals begin to function as normal and clinical trials resume, we will be there to continue to support our patients, doctors and scientists to get new medicines out to those that need them most.”

“The devastating impact of the COVID-19 (SARS-CoV-2) pandemic is being felt globally, highlighting the importance of medical research and the critical role it plays in our fight against deadly pathogens.

“From the beginning of 2020, we have seen unprecedented levels of international cooperation between individual researchers, public & private institutions and governments in the race to find a vaccine or treatment for COVID-19.

“The tireless efforts of the individuals involved combined with the focus and resources of the public and private institutions backing them, has meant significant progress has already been made in both our understanding and ability to treat COVID-19.

“These joint efforts are yielding significant results with several new diagnostic tests now in production, repurposed medications and innovative vaccines entering clinical trials, the power of working together in this time of crisis is being seen firsthand.

“Several potential treatments and vaccine candidates are now reaching clinical trials, a vital process to ensure both the efficacy and safety of these breakthroughs before being made available for wider use amongst the population.

“At HealthMatch, we know that this is a difficult time for many researchers and patients who have also had their clinical trials focussing on other conditions disrupted, delayed or abandoned. The anxiety we are all feeling waiting for the results of COVID-19 Clinical trials is the exact feeling many cancer patients and chronic illness sufferers feel when new medicine is delayed in clinical trials.

“We hope that as a wider take away from COVID-19, the spotlight is directed to the importance of supporting medical research and clinical trials to find new medicines for the many medical conditions for which we have no treatments.

 “And when this all settles, we’ve successfully flattened the curve and hospitals can begin to function again and clinical trials resume, we will be there to continue to support our patients, doctors and scientists to get new medicines out to those that need them most,” Gunawardena concluded.


As part of our Lead Machine Methodology we will help you get more leads, more customers and more business. Let us help you develop your digital marketing campaign

Digital Marketing is ideal in these tough times and it can replace face to face marketing with person to person marketing via the phone conference calls and webinars

Significant opportunity pipelines can be developed and continually topped up with the help of Digital Marketing so that deals can be made and deals can be closed

- Newsletter adverts in dynamic GIF slideshow formats

- News site adverts from small to large sizes also as dynamic GIF slideshow formats

- Guest Editorial - get your message out there and put your CEO in the spotlight

- Promotional News and Content - displayed on the homepage and all pages

- Leverage our proven event promotion methodology - The Lead Machine gets you leads

Contact Andrew our digital campaign designer on 0412 390 000 or via email



Security requirements such as confidentiality, integrity and authentication have become mandatory in most industries.

Data encryption methods previously used only by military and intelligence services have become common practice in all data transfer networks across all platforms, in all industries where information is sensitive and vital (financial and government institutions, critical infrastructure, data centres, and service providers).

Get the full details on Layer-1 encryption solutions straight from PacketLight’s optical networks experts.

This white paper titled, “When 1% of the Light Equals 100% of the Information” is a must read for anyone within the fiber optics, cybersecurity or related industry sectors.

To access click Download here.


Peter Dinham

Peter Dinham is a co-founder of iTWire and a 35-year veteran journalist and corporate communications consultant. He has worked as a journalist in all forms of media – newspapers/magazines, radio, television, press agency and now, online – including with the Canberra Times, The Examiner (Tasmania), the ABC and AAP-Reuters. As a freelance journalist he also had articles published in Australian and overseas magazines. He worked in the corporate communications/public relations sector, in-house with an airline, and as a senior executive in Australia of the world’s largest communications consultancy, Burson-Marsteller. He also ran his own communications consultancy and was a co-founder in Australia of the global photographic agency, the Image Bank (now Getty Images).



Recent Comments